![No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | Fierce Pharma No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1631128798/AJOVY%20Image.jpg/AJOVY%20Image.jpg?VersionId=syVEFjOv7_Oy_I9QN1IbMNNg6mpwQsTc)
No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | Fierce Pharma
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678530/5/Migraine+fact+3+of+3.jpg)
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
![Amazon.com: Beyond Migraine : The Migraine Association of Ireland and Teva Pharmaceuticals Ireland: Audible Books & Originals Amazon.com: Beyond Migraine : The Migraine Association of Ireland and Teva Pharmaceuticals Ireland: Audible Books & Originals](https://m.media-amazon.com/images/I/41ebInM-rKL._SL500_.jpg)
Amazon.com: Beyond Migraine : The Migraine Association of Ireland and Teva Pharmaceuticals Ireland: Audible Books & Originals
![Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire](https://mms.businesswire.com/media/20210408005437/en/713670/4/teva_RGB_JPEG.jpg)
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
![Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults](https://mma.prnewswire.com/media/1479280/Teva___Logo_2.jpg?p=twitter)
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults
![Teva to acquire Labrys Biologics, Inc.: Novel migraine prophylaxis treatment adds significant new dimension to Teva's growing pain care franchise - Drug Target Review Teva to acquire Labrys Biologics, Inc.: Novel migraine prophylaxis treatment adds significant new dimension to Teva's growing pain care franchise - Drug Target Review](http://www.drugtargetreview.com/wp-content/uploads/migraine.jpg)